PER 1.23% 8.0¢ percheron therapeutics limited

In the ann dated 20 Sept 2011 on ATL1102, ANP stated the...

  1. 1,496 Posts.
    In the ann dated 20 Sept 2011 on ATL1102, ANP stated the comparison value of another Stem Cell Mobilisation therapy, Mobobil:

    "One such complimentary therapy, Mozobil, has been approved for use in combination with the main agent G-CSF. First marketed in 2009, MozobilTM sales in 2010 were ~US$100Mill with peak sales potential estimated at US$350Mill per annum."
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.